Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMECLO: Electroconvulsive therapy vs. medication in clozapine-refractory symptoms
2021-006333-19Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of aripiprazole in schizophrenia and Schizophrenia Spectrum Disorders (SSD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: number of patients willing to be randomized. Started Apr 2022; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophreniaSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on 2021-006333-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006333-19.